Emmaus Life Sciences Announces Engagement of Strategic Business Relations and Professional Services Advisor

/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease,...

Related Keywords

Japan ,United States ,Americans ,Willis Lee ,Yutaka Niihara ,Sean Mcdonald ,Centers For Disease ,Committee On Addressing Sickle Cell Disease ,Prnewswire Emmaus Life Sciences Inc ,Company Contact ,Drug Administration ,Relations Company ,National Center On Birth Defects ,Blueprint For Action National Academy Of Sciences ,Emmaus Life Sciences ,A Market Awareness Program Targeting Financial Professionals ,Acorn Management Partners ,Emmaus Life Sciences Inc ,Acorn Management Partners Will Develop ,Market Awareness Program Targeting Financial ,Life Sciences ,Middle East North Africa ,Emmau Chairman ,Chief Executive ,Emmaus Life ,Chief Process Officer ,Management Partners ,Professional Relations ,Wall Street ,Corporate Reputation ,Prescribing Information ,Sickle Cell Disease ,National Center ,Birth Defects ,Developmental Disabilities ,Disease Control ,Addressing Sickle Cell Disease ,Strategic Plan ,Sciences Press ,Nc ,